Company Filing History:
1 out of 2,405 
1 out of 7 
1 out of 769 
Years Active: 2017
Title: The Innovations of Alessandro Pocai
Introduction
Alessandro Pocai is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of metabolic disorder treatments through his innovative research and development of peptide analogs.
Latest Patents
Pocai holds a patent for "Oxyntomodulin analogs," which describes peptide analogs of oxyntomodulin (OXM, glucagon-37). These analogs have been modified to resist cleavage and inactivation by dipeptidyl peptidase IV (DPP-IV), thereby increasing the in vivo half-life of the peptide. This innovation enables the peptide analog to function as a dual GLP-1/glucagon receptor (GCGR) agonist. The peptide analogs are particularly useful for treating metabolic disorders such as diabetes and obesity.
Career Highlights
Throughout his career, Pocai has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and MSD Italia S.r.l. His work has been instrumental in advancing therapeutic options for patients suffering from metabolic conditions.
Collaborations
Pocai has collaborated with esteemed colleagues such as Paul E. Carrington and George J. Eiermann, contributing to the development of innovative solutions in his field.
Conclusion
Alessandro Pocai's work exemplifies the impact of innovation in the treatment of metabolic disorders. His patented peptide analogs represent a significant advancement in medical science, offering hope for improved therapies for diabetes and obesity.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.